Stocks

ARS Pharmaceuticals SPRY

Health care sectorNasdaq

What to see in ARS Pharmaceuticals now

Is stock about to come to market?$1.6M

$1.6M of planned sales filed in 30 days · 0.3% of the units outstanding

Filed 10/01
Who bought more than 5%?5.3%

BlackRock holds 5.3% · +0.3pp on the report before

Filed 07/27
Is Wall Street adding or cutting?+3

206 13F filers hold it · +3 against the quarter before · shares held −3.6%

Holdings of 06/30

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
San Diego, California
Fiscal year end
12/31
Next earnings
11/10, estimated
  • $1.6M of planned sales filed in 30 days · 0.3% of the units outstandingFiled 10/01

Insider trades

Trade type
Alexander A. FitzpatrickChief Legal Officer
Open-market sale10b5-1 plan06/1206/123,355 sh$10.00$33,550−3.6%
Eric KarasChief Commercial Officer
Open-market sale10b5-1 plan06/1206/1225,000 sh$10.00$250,000−67.2%
Brian DorseyChief Operating Officer
Open-market sale25/11/1325/11/1421,828 sh$8.71$190,121.88−66.9%
Justin ChakmaChief Business Officer
Open-market sale25/11/1225/11/1430,000 sh$8.91$267,300−18.0%
Justin ChakmaChief Business Officer
Open-market sale25/11/1225/11/14136,380 sh$8.86$1,208,326.8−100.0%
All insider trades in ARS Pharmaceuticals

Planned sales

ARS PharmaceuticalsSPRY
100,000 sh$426,096.7710/01Filed 10/01
ARS PharmaceuticalsSPRY
100,000 sh$431,56009/30Filed 09/30
Richard E. LowenthalOfficer, Director, 10% Stockholder
ARS PharmaceuticalsSPRY
35,000 sh$176,99509/11Filed 09/11
ARS PharmaceuticalsSPRY
14,064 sh$69,761.6609/11Filed 09/11
Richard E. LowenthalOfficer, Director, 10% Stockholder
ARS PharmaceuticalsSPRY
75,000 sh$421,057.509/04Filed 09/04
Richard E. LowenthalOfficer, Director, 10% Stockholder
ARS PharmaceuticalsSPRY
19,805 sh$115,564.1609/03Filed 09/03
Richard E. LowenthalOfficer, Director, 10% Stockholder
ARS PharmaceuticalsSPRY
840 sh$4,999.7609/02Filed 09/02
Sarina TanimotoOfficer, 10% Stockholder
ARS PharmaceuticalsSPRY
45,388 sh$272,849.9609/01Filed 09/01
Sarina TanimotoOfficer, 10% Stockholder
ARS PharmaceuticalsSPRY
63,289 sh$368,099.1208/31Filed 08/31
Sarina TanimotoOfficer, 10% Stockholder
ARS PharmaceuticalsSPRY
25,000 sh$147,97008/20Filed 08/20
All planned sales of ARS Pharmaceuticals

26-week trading